Garlic supplementation and serum cholesterol: A meta-analysis

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 2, 2009, Pages 133-145

  Khoo, Y S K ^a   Aziz, Z ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Allicin; Allium sativum; Apolipoprotein B; Cardiovascular disease; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; CARDIOMAX; GARLIC EXTRACT; GARLICIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KYOLIC 100; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRINTANOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; GARLIC; HUMAN; HYPERCHOLESTEROLEMIA; META ANALYSIS; OUTCOME ASSESSMENT; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DIETARY SUPPLEMENTS; FEMALE; GARLIC; HUMANS; MALE; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 61349175255     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00998.x     Document Type: Review

References (49)

1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A (2005) European cardiovascular disease statistics. British Heart Foundation, London.
2. Callow AD (2006) Cardiovascular disease 2005 - the global picture. Vascular Pharmacology, 45, 302 307.
3. United Nations' Economic and Social Commission for Asia and the Pacific (UNESCAP). Statistical yearbook for Asia and the Pacific 2007. Available at: http://www.unescap.org/stat/data/syb2007/8-Chronic-diseases-and-other-health- risks-syb2007.asp (accessed 1 August 2008).
4. The Expert Panel (NCEP) 1988) Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Archives of Internal Medicine, 148, 36 39.
5. Roberts WC (1992) Atherosclerotic risk factors - are there ten, or is there only one? Atherosclerosis, 97, S5 S9.
6. Sadovsky R 2008) Using apolipoprotein B levels to assess cardiac risk. American Family Physician [Online]. Available at: http://www.aafp.org/afp/ 20030315/tips/21.html (accessed 4 February 2008).
7. Rahman K (2003) Garlic and aging: new insights into an old remedy. Ageing Research Reviews, 2, 39 56.
8. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y (2001) Intake of garlic and its bioactive components. The Journal of Nutrition, 131, S955 S962.
9. Staba EJ, Lash L, Staba JE (2001) A commentary on the effects of garlic extraction and formulation on product composition. The Journal of Nutrition, 131, S1118 S1119.
10. Matsuura H (2001) Saponins in garlic as modifiers of the risk of cardiovascular disease. The Journal of Nutrition, 131, S1000 S1005.
11. Spigelski D, Jones PJH (2001) Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutrition Reviews, 59, 236 241.
12. Yeh YY, Liu L (2001) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. The Journal of Nutrition, 131, S989 S993.
13. Sonova M, Sova P (2004) Pharmaceutical importance of Allium Sativum L. - hypolipemic effects in vitro and in vivo. Ceska a Slovenska Farmacie, 53, 117 123 (Czech).
14. Borek C (2006) Garlic reduces dementia and heart-disease risk. The Journal of Nutrition, 136, 810S 812S.
15. Warshafsky S, Kamer RS, Sivak SL (1993) Effect of garlic on total serum cholesterol: a meta-analysis. Annals of Internal Medicine, 119, 599 605.
16. Neil A, Silagy C (1994) Garlic: its cardio-protective properties. Current Opinion in Lipidology, 5, 6 10.
17. Rahman K (2001) Historical perspective on garlic and cardiovascular disease. The Journal of Nutrition, 131, S977 S979.
18. Banerjee SK, Maulik SK (2002) Effect of garlic on cardiovascular disorders: a review. Nutrition Journal, 1, 4 17.
19. Alder R, Lookinland S, Berry JA, Williams M (2003) A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. Journal of the American Academy of Nurse Practitioners, 15, 120 129.
20. Tattelman E (2005) Health effects of garlic. American Family Physician, 72, 103 106.
21. Rahman K, Lowe GM (2006) Garlic and cardiovascular disease: a critical review. The Journal of Nutrition, 136, S736 S740.
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Asssessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials, 17, 1 12.
23. Schulz KF, Grimes DA (2002) Sample size slippages in randomized trials: exclusions and the lost and wayward. Lancet, 359, 781 785.
24. Gavaghan DJ, Moore AR, McQay HJ (2000) An evaluation of heterogeneity tests in meta-analysis in pain using simulations of patient data. Pain, 85, 415 424.
25. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ, 327, 557 560.
26. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ, 315, 1533 1537.
27. Samson RR (1982) Effects of dietary garlic and temporal drift on platelet aggregation. Atherosclerosis, 44, 119 120.
28. Morris J, Burke V, Mori TA, Vandongen R, Beilin LJ (1995) Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study. Clinical and Experimental Pharmacology and Physiology, 22, 414 417.
29. De A Santos OS, Grunwald J (1993) Effect of garlic powder tablets on blood lipids and blood pressure - a six month placebo controlled, double blind study. British Journal of Clinical Research, 4, 37 44.
30. Gardner CD, Lawson LD, Block E, Chatterjee LM, Kiazand A, Balise RR, Kraemer HC (2007) Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia - a randomized clinical trial. Archives of Internal Medicine, 167, 346 353.
31. Isaacsohn JL, Moser M, Stein E, Dudley K, Davey JA, Liskov E, Black HR (1998) Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Archives of Internal Medicine, 158, 1189 1194.
32. Jain AK, Vargas R, Gotzkowsky S, McMahon FG (1993) Can garlic reduce levels of serum lipids? A controlled clinical study American Journal of Medicine, 94, 632 635.
33. Kannar D, Wattanapenpaiboon N, Savige GS, Wahlqvist ML (2001) Hypocholesterolemic effect of an enteric-coated garlic supplement. Journal of the American College of Nursing, 20, 225 231.
34. Kiesewetter H, Jung F, Jung EM et al. (1993) Effects of garlic coated tablets in peripheral arterial occlusive disease. The Clinical Investigator, 71, 383 386.
35. Mader FH (1990) Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittel-Forschung, 40, 1111 1116.
36. Neil HA, Silagy CA, Lancaster T et al. (1996) Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. Journal of the Royal College of Physicians of London, 30, 329 334.
37. Peleg A, Hershcovici T, Lipa R, Anbar R, Redler M, Beigel Y (2003) Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia. Israel Medical Association Journal, 5, 637 640.
38. Turner B, Mølgaard C, Marckmann P (2004) Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition, 92, 701 706.
39. van Doorn MB, Espirito Santo SM, Meijer P, Kamerling IM, Schoemaker RC, Dirsch V et al. (2006) Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects. The American Journal of Clinical Nutrition, 84, 1324 1329.
40. Zhang XH, Lowe D, Giles P, Fell S, Board AR, Baughan JA et al. (2000) A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners. Blood Coagulation and Fibrinolysis, 11, 67 74.
41. Zhang ZH, Lowe D, Giles P, Fell S, Connock MJ, Maslin DJ (2001) Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. The Journal of Nutrition, 131, 1471 1478.
42. Ernst E, Schmidt K (2004) Homotoxicology - a review of randomized clinical trials. European Journal of Clinical Pharmacology, 60, 299 306.
43. Stevinson C, Pittler MH, Ernst E (2000) Garlic for treating hypercholesterolemia: a meta-analysis of randomized clinical trials. Annals of Internal Medicine, 133, 420 429.
44. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidone L, Lawrence VA (2001) Garlic shows promise for improving some cardiovascular risk factors. Archives of Internal Medicine, 161, 813 824.
45. Mulrow C, Lawrence V, Ackermann R et al. (2000) Garlic: Effects on Cardiovascular Risks and Disease, Protective Effects Against Cancer, and Clinical Adverse Effects. Summary, Evidence Report/Technology Assessment No. 20. AHRQ Publication No. 01-E022, October 2000. Rockville, MD : Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov/ cliniclepcsums/garlicsm.htm (accessed 4 February 2008).
46. Brace LD (2002) Cardiovascular benefits of garlic (allium sativum L.). The Journal of Cardiovascular Nursing, 16, 33 49.
47. McRae MP (2005) A review of studies of garlic (Allium sativum) on serum lipids and blood pressure before and after 1994: does the amount of allicin released from garlic powder tablets play a role? Journal of Chiropractic Medicine, 4, 182 190.
48. Amagase H (2006) Clarifying the real bioactive constituents of garlic. The Journal of Nutrition, 136, 716S 725S.
49. Heck AM, DeWitt BA, Lukes AL (2000) Potential interactions between alternative therapies and warfarin. American Journal of Health System Pharmacy, 57, 1221 1230.